ArticleMolecular cancer therapeutics2014

Triple-negative breast cancer patients treated at MD Anderson Cancer Center in phase I trials: improved outcomes with combination chemotherapy and targeted agents.

Prasanth Ganesan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.